These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9598523)

  • 1. Nephrolithiasis from indinavir, a new human immunodeficiency virus drug.
    Lerner LB; Cendron M; Rous SN
    J Urol; 1998 Jun; 159(6):2074; discussion 2074-5. PubMed ID: 9598523
    [No Abstract]   [Full Text] [Related]  

  • 2. Indinavir nephrolithiasis in warm climates.
    Bach MC; Godofsky EW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Mar; 14(3):296-7. PubMed ID: 9117466
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistent nephrolithiasis after discontinuation of indinavir therapy.
    Polhemus ME; Aronson NE
    Clin Infect Dis; 1998 Dec; 27(6):1536-7. PubMed ID: 9868678
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed.
    Reiter WJ; Schön-Pernerstorfer H; Dorfinger K; Hofbauer J; Marberger M
    J Urol; 1999 Apr; 161(4):1082-4. PubMed ID: 10081842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystalluria and urinary tract abnormalities associated with indinavir.
    Clayman RV
    J Urol; 1998 Aug; 160(2):633. PubMed ID: 9679944
    [No Abstract]   [Full Text] [Related]  

  • 6. Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients.
    Brodie SB; Keller MJ; Ewenstein BM; Sax PE
    AIDS; 1998 Dec; 12(18):2433-7. PubMed ID: 9875581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case no. 3. Right flank pain. Crixivan lithiasis.
    Schenkman NS
    Tech Urol; 1999 Mar; 5(1):59-60. PubMed ID: 10374801
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nephrolithiasis in a HIV infected patient treated with indinavir].
    Brzósko S; Hryszko T; Panasiuk B; Prokopowicz D; Myśliwiec M
    Przegl Lek; 2001; 58(6):528-9. PubMed ID: 11816748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection.
    Malavaud B; Dinh B; Bonnet E; Izopet J; Payen JL; Marchou B
    Antivir Ther; 2000 Mar; 5(1):3-5. PubMed ID: 10846585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute renal failure due to indinavir crystalluria and nephrolithiasis: report of two cases.
    Berns JS; Cohen RM; Silverman M; Turner J
    Am J Kidney Dis; 1997 Oct; 30(4):558-60. PubMed ID: 9328372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of environmental temperature on incidence of indinavir-related nephrolithiasis.
    Martínez E; Leguizamón M; Mallolas J; Miró JM; Gatell JM
    Clin Infect Dis; 1999 Aug; 29(2):422-5. PubMed ID: 10476752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Crystalluria and nephrolithiasis during therapy with the protease inhibitor indinavir].
    Rickerts V; Kober A; Stille W
    Dtsch Med Wochenschr; 1997 Jun; 122(24):803. PubMed ID: 9229567
    [No Abstract]   [Full Text] [Related]  

  • 13. Anuria and acute renal failure resulting from indinavir sulfate induced nephrolithiasis.
    Witte M; Tobon A; Gruenenfelder J; Goldfarb R; Coburn M
    J Urol; 1998 Feb; 159(2):498-9. PubMed ID: 9649271
    [No Abstract]   [Full Text] [Related]  

  • 14. Indinavir, zidovudine, lamivudine: 3-year follow-up.
    Dworkin MS; Wan PT
    Ann Intern Med; 2001 Jan; 134(2):165. PubMed ID: 11177322
    [No Abstract]   [Full Text] [Related]  

  • 15. Indinavir-associated asymptomatic nephrolithiasis and renal cortex atrophy in two HIV-1 infected children.
    van Rossum AM; Dieleman JP; Fraaij PL; Cransberg K; Hartwig NG; Gyssens IC; de Groot R
    AIDS; 2001 Sep; 15(13):1745-7. PubMed ID: 11546957
    [No Abstract]   [Full Text] [Related]  

  • 16. Crystalluria and urinary tract abnormalities associated with indinavir.
    Kopp JB; Miller KD; Mican JA; Feuerstein IM; Vaughan E; Baker C; Pannell LK; Falloon J
    Ann Intern Med; 1997 Jul; 127(2):119-25. PubMed ID: 9230000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indinavir nephropathy.
    Tashima KT; Horowitz JD; Rosen S
    N Engl J Med; 1997 Jan; 336(2):138-40. PubMed ID: 8992346
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased prevalence and analysis of risk factors for indinavir nephrolithiasis.
    Saltel E; Angel JB; Futter NG; Walsh WG; O'Rourke K; Mahoney JE
    J Urol; 2000 Dec; 164(6):1895-7. PubMed ID: 11061951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
    Gulick RM; Mellors JW; Havlir D; Eron JJ; Meibohm A; Condra JH; Valentine FT; McMahon D; Gonzalez C; Jonas L; Emini EA; Chodakewitz JA; Isaacs R; Richman DD
    Ann Intern Med; 2000 Jul; 133(1):35-9. PubMed ID: 10877738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indinavir crystalluria: identification of patients at increased risk of developing nephrotoxicity.
    Trainor LD; Steinberg JP; Austin GW; Solomon HM
    Arch Pathol Lab Med; 1998 Mar; 122(3):256-9. PubMed ID: 9823864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.